#begin document (en_3192.txt); part 000
en_3192.txt	0	0	Our	PRP$	(TOP(NP*	-	-	-	-	*	(0)
en_3192.txt	0	1	Other	JJ	*	-	-	-	-	*	-
en_3192.txt	0	2	Drug	NNP	*	-	-	-	-	*	-
en_3192.txt	0	3	Problem	NNP	*))	-	-	-	-	*	-

en_3192.txt	0	0	MILAN	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	2	With	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	3	all	PDT	(NP*	-	-	-	-	*	-
en_3192.txt	0	4	the	DT	*	-	-	-	-	*	-
en_3192.txt	0	5	official	NN	*	-	-	-	-	*	-
en_3192.txt	0	6	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	7	media	NNS	*	-	-	-	-	*	-
en_3192.txt	0	8	attention	NN	*))	-	-	-	-	*	-
en_3192.txt	0	9	given	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	12	worldwide	JJ	*	-	-	-	-	*	-
en_3192.txt	0	13	trade	NN	*)	-	-	-	-	*	-
en_3192.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	illicit	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	16	drugs	NNS	*)))))))	-	-	-	-	*	-
en_3192.txt	0	17	,	,	*	-	-	-	-	*	-
en_3192.txt	0	18	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	19	public	NN	*)	-	-	-	-	*	-
en_3192.txt	0	20	has	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	21	at	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	22	most	RBS	(NP*))	-	-	-	-	*	-
en_3192.txt	0	23	a	DT	(NP(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	24	dim	JJ	*	-	-	-	-	*	-
en_3192.txt	0	25	awareness	NN	*)	-	-	-	-	*	-
en_3192.txt	0	26	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	27	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	28	serious	JJ	*	-	-	-	-	*	-
en_3192.txt	0	29	problems	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	30	affecting	VBG	(VP*	-	-	-	-	*	-
en_3192.txt	0	31	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	32	production	NN	*)))))	-	-	-	-	*	-
en_3192.txt	0	33	,	,	*	-	-	-	-	*	-
en_3192.txt	0	34	testing	NN	(NP*)	-	-	-	-	*	-
en_3192.txt	0	35	,	,	*	-	-	-	-	*	-
en_3192.txt	0	36	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	37	sale	NN	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	38	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	39	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	40	legal	JJ	*	-	-	-	-	*	-
en_3192.txt	0	41	kind	NN	*)	-	-	-	-	*	-
en_3192.txt	0	42	:	:	*	-	-	-	-	*	-
en_3192.txt	0	43	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	44	medicines	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	45	that	IN	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	46	we	PRP	(S(NP*)	-	-	-	-	*	(0)
en_3192.txt	0	47	take	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	48	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	49	treat	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	50	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	51	cure	VB	*	-	-	-	-	*	-
en_3192.txt	0	52	everything	NN	(NP*)	-	-	-	-	*	-
en_3192.txt	0	53	from	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	54	AIDS	NNP	(NP*))	-	-	-	-	*	-
en_3192.txt	0	55	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	56	Yellow	NNP	(NP*	-	-	-	-	*	-
en_3192.txt	0	57	Fever	NNP	*))))))))))))))	-	-	-	-	*	-
en_3192.txt	0	58	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(1
en_3192.txt	0	1	development	NN	*)	-	-	-	-	*	-
en_3192.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	3	new	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	4	drugs	NNS	*)))	-	-	-	-	*	1)
en_3192.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	a	DT	(NP*	-	-	-	-	*	(2
en_3192.txt	0	7	complex	JJ	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	8	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	9	lengthy	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	10	process	NN	*))	-	-	-	-	*	2)
en_3192.txt	0	11	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(1)
en_3192.txt	0	1	starts	VBZ	(VP(VP*	-	-	-	-	*	-
en_3192.txt	0	2	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	3	an	DT	(NP*	-	-	-	-	*	(3
en_3192.txt	0	4	idea	NN	*)))	-	-	-	-	*	3)
en_3192.txt	0	5	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	6	requires	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	8	wide	JJ	*	-	-	-	-	*	-
en_3192.txt	0	9	range	NN	*)	-	-	-	-	*	-
en_3192.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	11	skills	NNS	(NP*)))	-	-	-	-	*	-
en_3192.txt	0	12	to	TO	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	bring	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	that	DT	(NP*	-	-	-	-	*	(3
en_3192.txt	0	15	idea	NN	*)	-	-	-	-	*	3)
en_3192.txt	0	16	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	17	fruition	NN	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	18	:	:	*	-	-	-	-	*	-
en_3192.txt	0	19	synthesis	NN	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	20	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	21	extraction	NN	*)	-	-	-	-	*	-
en_3192.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	23	more	JJR	(NP(NP(NP(ADJP*	-	-	-	-	*	(4
en_3192.txt	0	24	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	25	less	JJR	*)	-	-	-	-	*	-
en_3192.txt	0	26	complicated	JJ	*	-	-	-	-	*	-
en_3192.txt	0	27	molecules	NNS	*)	-	-	-	-	*	4)
en_3192.txt	0	28	,	,	*	-	-	-	-	*	-
en_3192.txt	0	29	proof	NN	*)	-	-	-	-	*	-
en_3192.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	31	their	PRP$	(NP(NP*	-	-	-	-	*	(4)
en_3192.txt	0	32	therapeutic	JJ	*	-	-	-	-	*	-
en_3192.txt	0	33	effect	NN	*)	-	-	-	-	*	-
en_3192.txt	0	34	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	35	cell	NN	(NP*	-	-	-	-	*	-
en_3192.txt	0	36	cultures	NNS	*	-	-	-	-	*	-
en_3192.txt	0	37	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	38	animals	NNS	*))	-	-	-	-	*	-
en_3192.txt	0	39	,	,	*	-	-	-	-	*	-
en_3192.txt	0	40	testing	VBG	(VP*	-	-	-	-	*	-
en_3192.txt	0	41	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	42	toxicity	NN	(NP*)))	-	-	-	-	*	-
en_3192.txt	0	43	,	,	*)))))	-	-	-	-	*	-
en_3192.txt	0	44	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	45	clinical	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	46	studies	NNS	*))))))))	-	-	-	-	*	-
en_3192.txt	0	47	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Along	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	this	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	2	path	NN	*))	-	-	-	-	*	-
en_3192.txt	0	3	,	,	*	-	-	-	-	*	-
en_3192.txt	0	4	many	JJ	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	5	potential	JJ	*	-	-	-	-	*	-
en_3192.txt	0	6	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	7	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	withdrawn	VBN	(VP*)))	-	-	-	-	*	-
en_3192.txt	0	9	,	,	*	-	-	-	-	*	-
en_3192.txt	0	10	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	11	even	RB	(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	12	successfully	RB	(NP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	13	tested	VBN	*)	-	-	-	-	*	-
en_3192.txt	0	14	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	15	face	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	16	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	17	additional	JJ	*	-	-	-	-	*	-
en_3192.txt	0	18	hurdle	NN	*)	-	-	-	-	*	-
en_3192.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	20	regulatory	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	21	approval	NN	*)))))	-	-	-	-	*	-
en_3192.txt	0	22	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Finally	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	the	DT	(NP*	-	-	-	-	*	(5
en_3192.txt	0	3	drug	NN	*)	-	-	-	-	*	5)
en_3192.txt	0	4	reaches	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	(6
en_3192.txt	0	6	market	NN	*)	-	-	-	-	*	6)
en_3192.txt	0	7	,	,	*	-	-	-	-	*	-
en_3192.txt	0	8	where	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3192.txt	0	9	it	PRP	(S(NP*)	-	-	-	-	*	(5)
en_3192.txt	0	10	must	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	followed	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	closely	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	14	,	,	*	-	-	-	-	*	-
en_3192.txt	0	15	because	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	16	many	JJ	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	17	adverse	JJ	*	-	-	-	-	*	-
en_3192.txt	0	18	reactions	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	19	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	20	detected	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	21	only	RB	(PP*	-	-	-	-	*	-
en_3192.txt	0	22	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	23	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	24	large	JJ	*	-	-	-	-	*	-
en_3192.txt	0	25	number	NN	*)	-	-	-	-	*	-
en_3192.txt	0	26	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	27	patients	NNS	(NP*))))	-	-	-	-	*	-
en_3192.txt	0	28	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	29	after	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	30	years	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	32	use	NN	(NP*))))))))))))))))	-	-	-	-	*	-
en_3192.txt	0	33	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	2	several	JJ	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	3	thousand	CD	(NP*	-	-	-	-	*	-
en_3192.txt	0	4	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	5	currently	RB	(PP(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	6	on	IN	*	-	-	-	-	*	-
en_3192.txt	0	7	the	DT	(NP*	-	-	-	-	*	(6
en_3192.txt	0	8	market	NN	*)))	-	-	-	-	*	6)
en_3192.txt	0	9	,	,	*	-	-	-	-	*	-
en_3192.txt	0	10	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	12	worldwide	JJ	*	-	-	-	-	*	-
en_3192.txt	0	13	value	NN	*)	-	-	-	-	*	-
en_3192.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	about	IN	(NP(QP*	-	-	-	-	*	-
en_3192.txt	0	16	$	$	*	-	-	-	-	*	-
en_3192.txt	0	17	3	CD	*	-	-	-	-	*	-
en_3192.txt	0	18	trillion	CD	*))))))	-	-	-	-	*	-
en_3192.txt	0	19	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_3192.txt	0	1	conditions	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	3	the	DT	(NP*	-	-	-	-	*	(6
en_3192.txt	0	4	drug	NN	*	-	-	-	-	*	-
en_3192.txt	0	5	market	NN	*)))	-	-	-	-	*	6)
en_3192.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	far	RB	(ADVP*	-	-	-	-	*	-
en_3192.txt	0	8	from	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	9	optimal	JJ	(ADJP*))))	-	-	-	-	*	-
en_3192.txt	0	10	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Ideally	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	drugs	NNS	(NP*)	-	-	-	-	*	-
en_3192.txt	0	3	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	4	have	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	a	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	6	favorable	JJ	*	-	-	-	-	*	-
en_3192.txt	0	7	risk-benefit	JJ	*	-	-	-	-	*	-
en_3192.txt	0	8	ratio	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	9	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Compared	VBN	(TOP(S(S(VP*	-	-	-	-	*	-
en_3192.txt	0	1	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	2	other	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	3	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	6	same	JJ	*	-	-	-	-	*	-
en_3192.txt	0	7	indications	NNS	*))))))	-	-	-	-	*	-
en_3192.txt	0	8	,	,	*	-	-	-	-	*	-
en_3192.txt	0	9	new	JJ	(NP*	-	-	-	-	*	(7
en_3192.txt	0	10	drugs	NNS	*)	-	-	-	-	*	7)
en_3192.txt	0	11	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	selected	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	on	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	basis	NN	*)	-	-	-	-	*	-
en_3192.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	18	their	PRP$	(NP*	-	-	-	-	*	(7)
en_3192.txt	0	19	safety	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	20	,	,	*	-	-	-	-	*	-
en_3192.txt	0	21	effectiveness	NN	(NP*)	-	-	-	-	*	-
en_3192.txt	0	22	,	,	*	-	-	-	-	*	-
en_3192.txt	0	23	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	24	cost	NN	(NP*))))))	-	-	-	-	*	-
en_3192.txt	0	25	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_3192.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	2	financial	JJ	*	-	-	-	-	*	-
en_3192.txt	0	3	interests	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	involved	VBN	(VP*))	-	-	-	-	*	-
en_3192.txt	0	5	tend	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	7	distort	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	the	DT	(NP*	-	-	-	-	*	(2
en_3192.txt	0	9	process	NN	*)	-	-	-	-	*	2)
en_3192.txt	0	10	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	11	creating	VBG	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	12	incentives	NNS	(NP*	-	-	-	-	*	-
en_3192.txt	0	13	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	14	overestimate	VB	(VP(VP*	-	-	-	-	*	-
en_3192.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	benefits	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	18	new	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	19	drugs	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	20	,	,	*	-	-	-	-	*	-
en_3192.txt	0	21	underestimate	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	22	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	23	risks	NNS	*))	-	-	-	-	*	-
en_3192.txt	0	24	,	,	*	-	-	-	-	*	-
en_3192.txt	0	25	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	26	,	,	(PRN*	-	-	-	-	*	-
en_3192.txt	0	27	above	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	28	all	DT	(NP*))	-	-	-	-	*	-
en_3192.txt	0	29	,	,	*)	-	-	-	-	*	-
en_3192.txt	0	30	boost	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	31	prescriptions	NNS	(NP*)))))))))))))	-	-	-	-	*	-
en_3192.txt	0	32	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	What	WP	(TOP(SBARQ(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	1	can	MD	(SQ*	-	-	-	-	*	-
en_3192.txt	0	2	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	3	done	VBN	(VP*)))	-	-	-	-	*	-
en_3192.txt	0	4	?	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	First	RB	(TOP(X(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	new	JJ	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	3	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	always	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	6	offer	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	added	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	8	value	NN	*))))	-	-	-	-	*	-
en_3192.txt	0	9	–	SYM	(X(X*)	-	-	-	-	*	-
en_3192.txt	0	10	better	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	11	efficacy	NN	*)	-	-	-	-	*	-
en_3192.txt	0	12	,	,	*	-	-	-	-	*	-
en_3192.txt	0	13	lower	JJR	(NP*	-	-	-	-	*	-
en_3192.txt	0	14	toxicity	NN	*)	-	-	-	-	*	-
en_3192.txt	0	15	,	,	*	-	-	-	-	*	-
en_3192.txt	0	16	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	17	greater	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	18	ease	NN	*)	-	-	-	-	*	-
en_3192.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	20	treatment	NN	(NP*)))))	-	-	-	-	*	-
en_3192.txt	0	21	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Unfortunately	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	this	DT	(NP*)	-	-	-	-	*	-
en_3192.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	4	not	RB	*	-	-	-	-	*	-
en_3192.txt	0	5	required	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	7	current	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	8	legislation	NN	*))	-	-	-	-	*	-
en_3192.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	10	Europe	NNP	(NP*))	-	-	-	-	*	-
en_3192.txt	0	11	,	,	*	-	-	-	-	*	-
en_3192.txt	0	12	where	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3192.txt	0	13	only	JJ	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	14	quality	NN	*)	-	-	-	-	*	-
en_3192.txt	0	15	,	,	*	-	-	-	-	*	-
en_3192.txt	0	16	efficacy	NN	(NP*)	-	-	-	-	*	-
en_3192.txt	0	17	,	,	*	-	-	-	-	*	-
en_3192.txt	0	18	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	19	safety	NN	(NP*))	-	-	-	-	*	-
en_3192.txt	0	20	must	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	21	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	22	demonstrated	VBN	(VP*)))))	-	-	-	-	*	-
en_3192.txt	0	23	,	,	*	-	-	-	-	*	-
en_3192.txt	0	24	without	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	25	any	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	26	need	NN	*)	-	-	-	-	*	-
en_3192.txt	0	27	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	28	comparative	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	29	studies	NNS	*))))))	-	-	-	-	*	-
en_3192.txt	0	30	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	2	therefore	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	3	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	4	risk	NN	*	-	-	-	-	*	-
en_3192.txt	0	5	that	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	6	new	JJ	(S(NP*	-	-	-	-	*	(8
en_3192.txt	0	7	drugs	NNS	*)	-	-	-	-	*	8)
en_3192.txt	0	8	may	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	9	in	IN	(ADVP*	-	-	-	-	*	-
en_3192.txt	0	10	fact	NN	*)	-	-	-	-	*	-
en_3192.txt	0	11	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	worse	JJR	(ADJP(ADJP*)	-	-	-	-	*	-
en_3192.txt	0	13	than	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	14	products	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	15	already	RB	(PP(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	16	on	IN	*	-	-	-	-	*	-
en_3192.txt	0	17	the	DT	(NP*	-	-	-	-	*	(6
en_3192.txt	0	18	market	NN	*)))))))))))	-	-	-	-	*	6)
en_3192.txt	0	19	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	New	JJ	(TOP(S(NP*	-	-	-	-	*	(8
en_3192.txt	0	1	drugs	NNS	*)	-	-	-	-	*	8)
en_3192.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	3	often	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	4	tested	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	against	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	6	placebos	NNS	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	7	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	8	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	9	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	10	are	VBP	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	11	not	RB	*	-	-	-	-	*	-
en_3192.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	13	best	JJS	*	-	-	-	-	*	-
en_3192.txt	0	14	treatment	NN	*)	-	-	-	-	*	-
en_3192.txt	0	15	available	JJ	(ADJP*))	-	-	-	-	*	-
en_3192.txt	0	16	,	,	*	-	-	-	-	*	-
en_3192.txt	0	17	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	18	point	NN	*)	-	-	-	-	*	-
en_3192.txt	0	19	being	VBG	(VP*	-	-	-	-	*	-
en_3192.txt	0	20	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	21	demonstrate	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	22	that	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	23	the	DT	(S(NP*	-	-	-	-	*	(5
en_3192.txt	0	24	new	JJ	*	-	-	-	-	*	-
en_3192.txt	0	25	drug	NN	*)	-	-	-	-	*	5)
en_3192.txt	0	26	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	27	not	RB	*	-	-	-	-	*	-
en_3192.txt	0	28	inferior	JJ	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	29	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	30	any	DT	(NP*)))	-	-	-	-	*	-
en_3192.txt	0	31	already	RB	(PP(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	32	on	IN	*	-	-	-	-	*	-
en_3192.txt	0	33	the	DT	(NP*	-	-	-	-	*	(6
en_3192.txt	0	34	market	NN	*)))))))))))))))))	-	-	-	-	*	6)
en_3192.txt	0	35	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_3192.txt	0	1	it	PRP	(NP*)	-	-	-	-	*	(5)
en_3192.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	3	ethically	RB	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	4	questionable	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	6	test	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	8	drug	NN	*)	-	-	-	-	*	-
en_3192.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	10	``	``	(NP*	-	-	-	-	*	-
en_3192.txt	0	11	non-inferiority	JJ	*	-	-	-	-	*	-
en_3192.txt	0	12	,	,	*	-	-	-	-	*	-
en_3192.txt	0	13	''	''	*)))	-	-	-	-	*	-
en_3192.txt	0	14	because	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	15	patients	NNS	(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	16	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	17	exposed	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	18	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	19	potential	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	20	risks	NNS	*))	-	-	-	-	*	-
en_3192.txt	0	21	while	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	22	contributing	VBG	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	23	,	,	(PP*	-	-	-	-	*	-
en_3192.txt	0	24	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	25	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	26	best	JJS	*	-	-	-	-	*	-
en_3192.txt	0	27	case	NN	*))	-	-	-	-	*	-
en_3192.txt	0	28	,	,	*	-	-	-	-	*	-
en_3192.txt	0	29	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	30	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	31	development	NN	*)	-	-	-	-	*	-
en_3192.txt	0	32	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	33	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	34	drug	NN	*)	-	-	-	-	*	-
en_3192.txt	0	35	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	36	is	VBZ	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	37	no	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	38	better	JJR	*)	-	-	-	-	*	-
en_3192.txt	0	39	than	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	40	those	DT	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	41	already	RB	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	42	available	JJ	*)))))))))))))))))))))))	-	-	-	-	*	-
en_3192.txt	0	43	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Patients	NNPS	(TOP(S(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	1	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	2	informed	JJ	*	-	-	-	-	*	-
en_3192.txt	0	3	consent	NN	*)	-	-	-	-	*	-
en_3192.txt	0	4	usually	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	5	does	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	not	RB	*	-	-	-	-	*	-
en_3192.txt	0	7	provide	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	9	clear	JJ	*	-	-	-	-	*	-
en_3192.txt	0	10	description	NN	*)	-	-	-	-	*	-
en_3192.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	12	a	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	13	non-inferiority	JJ	*	-	-	-	-	*	-
en_3192.txt	0	14	trial	NN	*))))))	-	-	-	-	*	-
en_3192.txt	0	15	,	,	*	-	-	-	-	*	-
en_3192.txt	0	16	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	17	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	18	lack	NN	*)	-	-	-	-	*	-
en_3192.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	20	added	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	21	value	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	22	indicates	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	23	that	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	24	in	IN	(S(PP*	-	-	-	-	*	-
en_3192.txt	0	25	many	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	26	cases	NNS	*))	-	-	-	-	*	-
en_3192.txt	0	27	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	28	development	NN	*)	-	-	-	-	*	-
en_3192.txt	0	29	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	30	a	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	31	new	JJ	*	-	-	-	-	*	-
en_3192.txt	0	32	drug	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	33	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	34	driven	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	35	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	36	commercial	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	37	aims	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	38	rather	RB	(CONJP*	-	-	-	-	*	-
en_3192.txt	0	39	than	IN	*)	-	-	-	-	*	-
en_3192.txt	0	40	patients	NNS	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	41	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	42	needs	NNS	*)))))))))	-	-	-	-	*	-
en_3192.txt	0	43	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Second	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	improvement	NN	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	4	drug	NN	(NP*	-	-	-	-	*	-
en_3192.txt	0	5	development	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	6	requires	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	more	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	8	transparency	NN	*)	-	-	-	-	*	-
en_3192.txt	0	9	from	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	11	regulatory	JJ	*	-	-	-	-	*	-
en_3192.txt	0	12	bodies	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	13	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	At	IN	(TOP(S(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	present	NN	(NP*))	-	-	-	-	*	-
en_3192.txt	0	2	,	,	*	-	-	-	-	*	-
en_3192.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	4	new	JJ	*	-	-	-	-	*	-
en_3192.txt	0	5	drug	NN	*	-	-	-	-	*	-
en_3192.txt	0	6	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	7	s	JJ	*	-	-	-	-	*	-
en_3192.txt	0	8	producer	NN	*)	-	-	-	-	*	-
en_3192.txt	0	9	prepares	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	11	entire	JJ	*	-	-	-	-	*	-
en_3192.txt	0	12	dossier	NN	*)	-	-	-	-	*	-
en_3192.txt	0	13	presented	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	regulatory	JJ	*	-	-	-	-	*	-
en_3192.txt	0	17	authority	NN	*)	-	-	-	-	*	-
en_3192.txt	0	18	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	19	approval	NN	(NP*))))))))	-	-	-	-	*	-
en_3192.txt	0	20	;	:	*	-	-	-	-	*	-
en_3192.txt	0	21	in	IN	(S(PP*	-	-	-	-	*	-
en_3192.txt	0	22	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	23	interests	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	25	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	26	public	NN	*))))	-	-	-	-	*	-
en_3192.txt	0	27	,	,	*	-	-	-	-	*	-
en_3192.txt	0	28	at	IN	(NP(NP(QP*	-	-	-	-	*	-
en_3192.txt	0	29	least	JJS	*	-	-	-	-	*	-
en_3192.txt	0	30	one	CD	*))	-	-	-	-	*	-
en_3192.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	32	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	33	clinical	JJ	*	-	-	-	-	*	-
en_3192.txt	0	34	trials	NNS	*)))	-	-	-	-	*	-
en_3192.txt	0	35	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	36	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	37	carried	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	38	out	RP	(PRT*)	-	-	-	-	*	-
en_3192.txt	0	39	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	40	an	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	41	independent	JJ	*	-	-	-	-	*	-
en_3192.txt	0	42	non-profit	JJ	*	-	-	-	-	*	-
en_3192.txt	0	43	organization	NN	*))))))	-	-	-	-	*	-
en_3192.txt	0	44	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	only	RB	(NP*	-	-	-	-	*	-
en_3192.txt	0	3	the	DT	*	-	-	-	-	*	-
en_3192.txt	0	4	regulators	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	5	can	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	examine	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	8	dossiers	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	9	,	,	*	-	-	-	-	*	-
en_3192.txt	0	10	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	11	are	VBP	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	12	highly	RB	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	13	confidential	JJ	*)))))))	-	-	-	-	*	-
en_3192.txt	0	14	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	2	unacceptable	JJ	(ADJP*)	-	-	-	-	*	-
en_3192.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	4	patients	NNS	(S(NP(NP*)	-	-	-	-	*	(9
en_3192.txt	0	5	participating	VBG	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	voluntarily	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	8	clinical	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	9	trials	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	10	,	,	*	-	-	-	-	*	-
en_3192.txt	0	11	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	12	their	PRP$	(NP*	-	-	-	-	*	(9)
en_3192.txt	0	13	representatives	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	14	,	,	*))))	-	-	-	-	*	9)
en_3192.txt	0	15	have	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	16	no	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	17	right	NN	*	-	-	-	-	*	-
en_3192.txt	0	18	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	19	see	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	20	data	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	21	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	22	would	MD	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	23	not	RB	*	-	-	-	-	*	-
en_3192.txt	0	24	exist	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	25	without	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	26	them	PRP	(NP*)))))))))))))))	-	-	-	-	*	(9)
en_3192.txt	0	27	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Third	JJ	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	better	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	3	conditions	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	6	approval	NN	*)	-	-	-	-	*	-
en_3192.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	8	new	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	9	drugs	NNS	*)))))	-	-	-	-	*	-
en_3192.txt	0	10	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	matched	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	14	better	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	15	use	NN	*)	-	-	-	-	*	-
en_3192.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	17	drugs	NNS	(NP*))	-	-	-	-	*	-
en_3192.txt	0	18	,	,	*	-	-	-	-	*	-
en_3192.txt	0	19	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	20	requires	VBZ	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	21	better	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	22	information	NN	*)	-	-	-	-	*	-
en_3192.txt	0	23	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	24	prescribers	NNS	(NP*)))))))))))	-	-	-	-	*	-
en_3192.txt	0	25	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Today	NN	(TOP(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	information	NN	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	3	provided	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	4	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	5	drug	NN	(NP*	-	-	-	-	*	-
en_3192.txt	0	6	makers	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	7	largely	RB	(VP(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	8	predominates	VBZ	*	-	-	-	-	*	-
en_3192.txt	0	9	over	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	10	independent	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	11	information	NN	*)))	-	-	-	-	*	-
en_3192.txt	0	12	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	As	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	a	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	2	result	NN	*))	-	-	-	-	*	-
en_3192.txt	0	3	,	,	*	-	-	-	-	*	-
en_3192.txt	0	4	certain	JJ	(NP*	-	-	-	-	*	(10
en_3192.txt	0	5	drugs	NNS	*)	-	-	-	-	*	10)
en_3192.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	used	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	much	RB	(ADVP(ADVP*	-	-	-	-	*	-
en_3192.txt	0	9	more	RBR	*	-	-	-	-	*	-
en_3192.txt	0	10	frequently	RB	*)	-	-	-	-	*	-
en_3192.txt	0	11	than	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	12	would	MD	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	13	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	expected	VBN	(VP*))))))	-	-	-	-	*	-
en_3192.txt	0	15	from	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	16	their	PRP$	(NP*	-	-	-	-	*	(10)
en_3192.txt	0	17	approved	VBN	*	-	-	-	-	*	-
en_3192.txt	0	18	indications	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	19	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	This	DT	(TOP(S(NP*	-	-	-	-	*	(11
en_3192.txt	0	1	so-called	JJ	*	-	-	-	-	*	-
en_3192.txt	0	2	``	``	*	-	-	-	-	*	-
en_3192.txt	0	3	off-label	JJ	*	-	-	-	-	*	-
en_3192.txt	0	4	''	''	*	-	-	-	-	*	-
en_3192.txt	0	5	use	NN	*)	-	-	-	-	*	11)
en_3192.txt	0	6	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	sustained	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	9	continuous	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	10	propaganda	NN	*)	-	-	-	-	*	-
en_3192.txt	0	11	aimed	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	not	RB	(PP(CONJP*	-	-	-	-	*	-
en_3192.txt	0	13	only	RB	*)	-	-	-	-	*	-
en_3192.txt	0	14	at	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	doctors	NNS	(NP*))	-	-	-	-	*	-
en_3192.txt	0	16	,	,	*	-	-	-	-	*	-
en_3192.txt	0	17	but	CC	(CONJP*	-	-	-	-	*	-
en_3192.txt	0	18	also	RB	*)	-	-	-	-	*	-
en_3192.txt	0	19	directly	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	20	at	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	21	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	22	public	NN	*))))))))	-	-	-	-	*	-
en_3192.txt	0	23	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Direct	JJ	(TOP(S(NP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	1	but	CC	*	-	-	-	-	*	-
en_3192.txt	0	2	shadowy	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	3	information	NN	*)	-	-	-	-	*	-
en_3192.txt	0	4	tends	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	6	lead	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	7	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	8	``	``	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	9	disease	NN	*	-	-	-	-	*	-
en_3192.txt	0	10	mongering	NN	*	-	-	-	-	*	-
en_3192.txt	0	11	''	''	*)	-	-	-	-	*	-
en_3192.txt	0	12	–	SYM	(X*)	-	-	-	-	*	-
en_3192.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	14	creation	NN	*)	-	-	-	-	*	-
en_3192.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	16	diseases	NNS	(NP*)))))	-	-	-	-	*	-
en_3192.txt	0	17	in	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	18	order	NN	*	-	-	-	-	*	-
en_3192.txt	0	19	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	20	boost	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	21	prescriptions	NNS	(NP*)))))))))	-	-	-	-	*	-
en_3192.txt	0	22	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_3192.txt	0	2	,	,	*	-	-	-	-	*	-
en_3192.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	4	concept	NN	*)	-	-	-	-	*	-
en_3192.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	6	``	``	(NP*	-	-	-	-	*	-
en_3192.txt	0	7	pre-hypertension	JJ	*	-	-	-	-	*	-
en_3192.txt	0	8	''	''	*)))	-	-	-	-	*	-
en_3192.txt	0	9	could	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	10	extend	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	(11
en_3192.txt	0	12	use	NN	*)	-	-	-	-	*	-
en_3192.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	14	anti-hypertensive	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	15	drugs	NNS	*)))	-	-	-	-	*	11)
en_3192.txt	0	16	dramatically	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	17	,	,	*	-	-	-	-	*	-
en_3192.txt	0	18	because	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	19	everybody	NNS	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	20	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	21	s	JJ	*	-	-	-	-	*	-
en_3192.txt	0	22	blood	NN	*	-	-	-	-	*	-
en_3192.txt	0	23	pressure	NN	*)	-	-	-	-	*	-
en_3192.txt	0	24	rises	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	25	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	26	age	NN	(NP*)))))))	-	-	-	-	*	-
en_3192.txt	0	27	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Likewise	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	3	notion	NN	*	-	-	-	-	*	-
en_3192.txt	0	4	that	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	5	blood	NN	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	6	cholesterol	NN	*)	-	-	-	-	*	-
en_3192.txt	0	7	should	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	9	as	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	10	low	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	11	as	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	12	possible	JJ	(ADJP*))))))))	-	-	-	-	*	-
en_3192.txt	0	13	clears	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	15	path	NN	*)	-	-	-	-	*	-
en_3192.txt	0	16	to	TO	(PP*	-	-	-	-	*	-
en_3192.txt	0	17	treating	VBG	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	18	healthy	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	19	people	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	20	with	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	21	anti-cholesteremic	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	22	agents	NNS	*)))))))	-	-	-	-	*	-
en_3192.txt	0	23	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Clearly	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	health	NN	(NP*	-	-	-	-	*	-
en_3192.txt	0	3	authorities	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	must	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	take	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	closer	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	7	control	NN	*)	-	-	-	-	*	-
en_3192.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	9	information	NN	(NP*)))	-	-	-	-	*	-
en_3192.txt	0	10	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	11	becoming	VBG	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	12	more	RBR	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	13	responsible	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	14	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	15	physicians	NNS	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	17	continuous	JJ	*	-	-	-	-	*	-
en_3192.txt	0	18	education	NN	*)))))))	-	-	-	-	*	-
en_3192.txt	0	19	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	If	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_3192.txt	0	1	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	2	conditions	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	4	drug	NN	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	5	approval	NN	*)	-	-	-	-	*	-
en_3192.txt	0	6	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	7	marketing	NN	(NP*))))	-	-	-	-	*	-
en_3192.txt	0	8	become	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	9	more	RBR	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	10	severe	JJ	*))))	-	-	-	-	*	-
en_3192.txt	0	11	,	,	*	-	-	-	-	*	-
en_3192.txt	0	12	pharmaceutical	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	13	companies	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	14	will	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	15	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	16	forced	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	17	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	18	produce	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	19	fewer	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	20	me-too	JJ	*	-	-	-	-	*	-
en_3192.txt	0	21	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	22	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	23	more	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	24	products	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	25	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	26	clinical	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	27	importance	NN	*))))))))))	-	-	-	-	*	-
en_3192.txt	0	28	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Requiring	VBG	(TOP(S(S(PP*	-	-	-	-	*	-
en_3192.txt	0	1	longer	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	2	testing	NN	*	-	-	-	-	*	-
en_3192.txt	0	3	periods	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	4	,	,	*	-	-	-	-	*	-
en_3192.txt	0	5	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	6	possibly	RB	(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	7	extra	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	8	resources	NNS	*)))	-	-	-	-	*	-
en_3192.txt	0	9	,	,	*	-	-	-	-	*	-
en_3192.txt	0	10	could	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	compensated	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	14	new	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	15	drugs	NNS	*	-	-	-	-	*	-
en_3192.txt	0	16	'	POS	*)	-	-	-	-	*	-
en_3192.txt	0	17	greater	JJR	*	-	-	-	-	*	-
en_3192.txt	0	18	longevity	NN	*))	-	-	-	-	*	-
en_3192.txt	0	19	on	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	20	the	DT	(NP*	-	-	-	-	*	(6
en_3192.txt	0	21	market	NN	*))))))	-	-	-	-	*	6)
en_3192.txt	0	22	,	,	*	-	-	-	-	*	-
en_3192.txt	0	23	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	24	patent	NN	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	25	coverage	NN	*)	-	-	-	-	*	-
en_3192.txt	0	26	could	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	27	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	28	extended	VBN	(VP*))))	-	-	-	-	*	-
en_3192.txt	0	29	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	Finally	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	1	,	,	*	-	-	-	-	*	-
en_3192.txt	0	2	incentives	NNS	(NP*)	-	-	-	-	*	-
en_3192.txt	0	3	must	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	5	found	VBN	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	7	encourage	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	pharmaceutical	JJ	(S(NP*	-	-	-	-	*	-
en_3192.txt	0	9	companies	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	10	to	TO	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	develop	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	12	drugs	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	13	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	14	fulfill	VBP	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	needs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	18	patients	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	19	still	RB	(VP(ADVP*)	-	-	-	-	*	-
en_3192.txt	0	20	awaiting	VBG	*	-	-	-	-	*	-
en_3192.txt	0	21	therapy	NN	(NP*))))))))))))))))))	-	-	-	-	*	-
en_3192.txt	0	22	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	2	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_3192.txt	0	3	than	IN	*	-	-	-	-	*	-
en_3192.txt	0	4	6,000	CD	*)	-	-	-	-	*	-
en_3192.txt	0	5	rare	JJ	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	6	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	7	neglected	VBN	*)	-	-	-	-	*	-
en_3192.txt	0	8	diseases	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	9	–	SYM	(X(X*)	-	-	-	-	*	-
en_3192.txt	0	10	many	JJ	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	12	developing	VBG	(NP*	-	-	-	-	*	-
en_3192.txt	0	13	countries	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	14	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	15	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	16	lack	VBP	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	17	remedies	NNS	(NP*)))))))	-	-	-	-	*	-
en_3192.txt	0	18	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_3192.txt	0	1	challenge	NN	*)	-	-	-	-	*	-
en_3192.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	3	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3192.txt	0	4	to	TO	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	5	produce	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	6	new	JJ	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	7	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	8	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	9	–	SYM	(S(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	10	because	IN	(SBAR*	-	-	-	-	*	-
en_3192.txt	0	11	patients	NNS	(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	12	are	VBP	(VP*	-	-	-	-	*	-
en_3192.txt	0	13	too	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	14	few	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	15	or	CC	*	-	-	-	-	*	-
en_3192.txt	0	16	too	RB	(ADJP*	-	-	-	-	*	-
en_3192.txt	0	17	poor	JJ	*))))))	-	-	-	-	*	-
en_3192.txt	0	18	–	SYM	(NP*)	-	-	-	-	*	-
en_3192.txt	0	19	promise	VBP	(S(VP*	-	-	-	-	*	-
en_3192.txt	0	20	very	RB	(NP(ADJP*	-	-	-	-	*	-
en_3192.txt	0	21	limited	JJ	*)	-	-	-	-	*	-
en_3192.txt	0	22	returns	NNS	*)))))))))))	-	-	-	-	*	-
en_3192.txt	0	23	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	1	partnership	NN	*)	-	-	-	-	*	-
en_3192.txt	0	2	between	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	3	governments	NNS	(NP(NP*)	-	-	-	-	*	-
en_3192.txt	0	4	,	,	*	-	-	-	-	*	-
en_3192.txt	0	5	non-profit	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	6	research	NN	*	-	-	-	-	*	-
en_3192.txt	0	7	institutions	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	8	,	,	*	-	-	-	-	*	-
en_3192.txt	0	9	charities	NNS	(NP*)	-	-	-	-	*	-
en_3192.txt	0	10	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	11	pharmaceutical	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	12	companies	NNS	*))))	-	-	-	-	*	-
en_3192.txt	0	13	might	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	14	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	15	one	CD	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	16	way	NN	*)	-	-	-	-	*	-
en_3192.txt	0	17	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_3192.txt	0	18	clean	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	19	up	RP	(PRT*)	-	-	-	-	*	-
en_3192.txt	0	20	the	DT	(NP*	-	-	-	-	*	(2
en_3192.txt	0	21	approval	NN	*	-	-	-	-	*	-
en_3192.txt	0	22	process	NN	*)	-	-	-	-	*	2)
en_3192.txt	0	23	for	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	24	new	JJ	(NP*	-	-	-	-	*	-
en_3192.txt	0	25	drugs	NNS	*)))))))))	-	-	-	-	*	-
en_3192.txt	0	26	.	.	*))	-	-	-	-	*	-

en_3192.txt	0	0	If	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_3192.txt	0	1	public	JJ	(S(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	2	awareness	NN	*)	-	-	-	-	*	-
en_3192.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_3192.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_3192.txt	0	5	current	JJ	*	-	-	-	-	*	-
en_3192.txt	0	6	problems	NNS	*)))	-	-	-	-	*	-
en_3192.txt	0	7	stimulates	VBZ	(VP*	-	-	-	-	*	-
en_3192.txt	0	8	politicians	NNS	(S(NP*)	-	-	-	-	*	-
en_3192.txt	0	9	to	TO	(VP*	-	-	-	-	*	-
en_3192.txt	0	10	find	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	12	solution	NN	*)	-	-	-	-	*	-
en_3192.txt	0	13	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3192.txt	0	14	works	VBZ	(S(VP*))))))))))	-	-	-	-	*	-
en_3192.txt	0	15	,	,	*	-	-	-	-	*	-
en_3192.txt	0	16	better	JJR	(NP(NP*	-	-	-	-	*	-
en_3192.txt	0	17	drugs	NNS	*)	-	-	-	-	*	-
en_3192.txt	0	18	and	CC	*	-	-	-	-	*	-
en_3192.txt	0	19	better	JJR	(NP*	-	-	-	-	*	-
en_3192.txt	0	20	drug	NN	*	-	-	-	-	*	-
en_3192.txt	0	21	use	NN	*))	-	-	-	-	*	-
en_3192.txt	0	22	will	MD	(VP*	-	-	-	-	*	-
en_3192.txt	0	23	be	VB	(VP*	-	-	-	-	*	-
en_3192.txt	0	24	achievable	JJ	(ADJP*)))	-	-	-	-	*	-
en_3192.txt	0	25	.	.	*))	-	-	-	-	*	-

#end document
